Leukocyte matrix metalloproteinase and tissue inhibitor gene expression patterns in children with primary hypertension

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) play an important role in cardiovascular remodeling. The aim of the study was to analyze MMP/TIMP genes expression in peripheral blood leukocytes of 80 hypertensive children (15.1？±？2.0 years) in comparison with age-matched 78 normotensive children (14.6？±？2.0 years; n.s.). TIMP and MMP expression in peripheral blood leukocytes was assessed by quantitative real-time PCR. Hypertensive children independently of age, sex, and body mass index had greater expression of MMP-2 than normotensive controls (p？=？0.0001). Patients with left ventricular hypertrophy had greater expression of MMP-14 than patients with normal left ventricular mass (p？=？0.006) and TIMP-2 expression correlated with carotid wall cross-sectional area (p？=？0.03; r？=？0.238). MMP-14 expression correlated with BMI-SDS (p？=？0.001; r？=？0.371), waist circumference-SDS (p？=？0.016; r？=？0.290), hsCRP (p？=？0.003; r？=？0.350), serum HDL-cholesterol (p？=？0.008; r？=？？0.304), and serum uric acid (p？=？0.0001; r？=？0.394). In conclusion, hypertensive adolescents presented significant alterations of MMP/TIMP expression pattern in comparison with normotensive peers. Moreover, altered MMP/TIMP expression was associated with hypertensive target organ damage and metabolic abnormalities